Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Schering-Plough's p53 gene therapy continues to make impressive progress

Nov. 27, 1998

Onyx reports encouraging phase II results of ONYX-015 in head and neck cancer

Nov. 27, 1998

Novel antitumor vinca alkaloids patented by Pierre Fabre

Nov. 26, 1998

Onyx presents new addition to anticancer arsenal at gene therapy conference

Nov. 26, 1998

Ligand initiates phase II trial with Targretin capsules for treatment of breast cancer

Nov. 26, 1998

New combretastatin A-4 derivative and prodrug profiled at ongoing scientific meeting

Nov. 25, 1998

Efficacy trial of new prostate cancer treatment initiated at eight leading research centers

Nov. 25, 1998

Tanabe presents water-soluble taxane with better activity than paclitaxel and docetaxel

Nov. 25, 1998

MGI Pharma initiates phase II study of MGI-114 in pancreatic cancer patients

Nov. 25, 1998

New agents for glioblastoma in preclinical testing at Wayne Hughes Institute

Nov. 24, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...